A 1-Year Community-Based Health Economic Study of Ciprofloxacin vs Usual Antibiotic Treatment in Acute Exacerbations of Chronic Bronchitis
- 1 January 1998
- Vol. 113 (1), 131-141
- https://doi.org/10.1378/chest.113.1.131
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Two-state mixed renewal processes for chronic diseaseStatistics in Medicine, 1999
- Recommendations for Reporting Cost-effectiveness AnalysesJAMA, 1996
- Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tractAmerican Journal Of Medicine, 1995
- A Prospective Randomised Parallel Single-Blind Comparison of Oral Ciprofloxacin with Oral Cotrimoxazole in the Treatment of Respiratory Tract Infections in Patients with Chronic Obstructive Lung DiseaseClinical Drug Investigation, 1994
- Guidelines for Economic Analysis of Pharmaceutical ProductsPharmacoEconomics, 1993
- Update on Mechanisms and Prevalence of Antimicrobial Resistance in Haemophilus influenzaeClinical Infectious Diseases, 1992
- Comparison of ciprofloxacin with ampicillin in acute infectious exacerbations of chronic bronchitisAmerican Journal Of Medicine, 1989
- Epidemiology of Chronic Airways DiseaseChest, 1989
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1987
- Expressions of morbidity in general practice.BMJ, 1971